Recently, the research results of the first-in-human (FIH) surgery of the AGIBOT Laparoscopic Surgical Robot independently developed by AGIBOT Medical Technology (Suzhou) Co., Ltd. (AGIBOT) were publicly released in the January 2024 issue of the ISTIC-indexed Journal of Minimally Invasive Urology.

March 30, 2024, AGIBOT Medical Technology (Suzhou) Co., Ltd. (AGIBOT) proudly announces the successful completion of urology registration clinical trials for its independently developed AGIBOT Laparoscopic Surgical Robot. Professor Zhang Xuepei’s team at The First Affiliated Hospital of Zhengzhou University performed the final case, in which a robot-assisted partial nephrectomy, marking full enrollment completion.

On 9 March 2024, the launch conference of the 5G Precision Minimally Invasive Surgery Alliance, hosted by the Seventh Medical Centre of the General Hospital of the People’s Liberation Army (PLA), was successfully held in Beijing, China.

On March 8, 2024, AGIBOT Medical Technology (Suzhou) Co., Ltd. (AGIBOT) announces the successful completion of first-center enrollment in its urology registration clinical trial. The Nanjing Drum Tower Hospital team led by Professor Guo Hongqian concluded all 37 registered cases, including 2 robot-assisted radical prostatectomies performed.